Takeda Pharmaceutical Profit Margin 2007-2020 | TAK

Current and historical gross margin, operating margin and net profit margin for Takeda Pharmaceutical (TAK) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Takeda Pharmaceutical net profit margin as of March 31, 2020 is 1.37%.
Takeda Pharmaceutical Annual Profit Margins
Takeda Pharmaceutical Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $53.912B $30.200B
Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company, engaged in manufacturing, marketing, and importing/exporting pharmaceutical drugs. Takeda's core business comprise of ethical drugs and its portfolio includes lansoprazole for the treatment of peptic ulcers, leuprolide acetate for the treatment of prostate cancer and endometriosis, pioglitazone hydrocholoride for the treatment of diabetes, and candesartan cilexetil for the treatment of hypertension. The Company promotes enhancing R&D pipeline, while concentrating its management resources to the four core therapeutic areas: lifestyle-related diseases, oncology and urological diseases, central nervous system disease and gastroenterological diseases. It operates in two segments- Ethical drug business and Consumer healthcare business. Consumer healthcare business provides Alinamin (vitamin B1 derivative preparations, etc.), Benza (cold remedies). Takeda Pharmaceutical Company Limited is headquartered in Osaka, Japan.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $65.689B 37.28
Astellas Pharma (ALPMY) Japan $29.844B 15.12
UCB SA (UCBJF) Belgium $23.924B 0.00
Eisai (ESALY) Japan $23.752B 20.59
Merck (MKGAF) Germany $16.013B 21.00
Grifols, S.A (GRFS) Spain $12.830B 15.95
Catalent (CTLT) United States $12.000B 46.39
Neurocrine Biosciences (NBIX) United States $11.708B 54.11
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $9.945B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 0.00
Ionis Pharmaceuticals (IONS) United States $8.504B 45.22
IPSEN SA ADR (IPSEY) France $7.733B 0.00
Orion OYJ (ORINY) Finland $7.077B 31.71
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.349B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $5.842B 9.35
United Therapeutics (UTHR) United States $5.103B 9.67
STADA ARZNEIMI (STDAF) Germany $4.916B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $4.695B 512.56
Nektar Therapeutics (NKTR) United States $4.158B 0.00
Evotec AG (EVTCY) Germany $4.040B 108.88
Hypermarcas (HYPMY) Brazil $3.793B 13.95
FibroGen (FGEN) United States $3.668B 0.00
ChemoCentryx (CCXI) United States $3.499B 0.00
PTC Therapeutics (PTCT) United States $3.457B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.517B 10.34
Pacira BioSciences (PCRX) United States $2.341B 47.91
Cronos Group (CRON) Canada $2.187B 62.70
Sage Therapeutics (SAGE) United States $2.135B 0.00
Corcept Therapeutics (CORT) United States $1.813B 17.98
Xencor (XNCR) United States $1.783B 0.00
USANA Health Sciences (USNA) United States $1.765B 18.11
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.658B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.599B 12.23
Akebia Therapeutics (AKBA) United States $1.541B 0.00
Indivior (INVVY) United States $1.488B 18.47
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.470B 15.84
Zogenix (ZGNX) United States $1.466B 0.00
Heron Therapeutics (HRTX) United States $1.418B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.338B 0.00
Esperion Therapeutics (ESPR) United States $1.314B 0.00
Karyopharm Therapeutics (KPTI) United States $1.302B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.200B 0.00
Translate Bio (TBIO) United States $1.104B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.001B 44.66
Tilray (TLRY) Canada $0.933B 0.00
VAXART, INC (VXRT) United States $0.899B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.873B 0.00
Endo (ENDP) Ireland $0.781B 1.21
ImmunoGen (IMGN) United States $0.736B 0.00
Aerie Pharmaceuticals (AERI) United States $0.622B 0.00
Radius Health (RDUS) United States $0.617B 0.00
Collegium Pharmaceutical (COLL) United States $0.563B 0.00
Trillium Therapeutics (TRIL) Canada $0.557B 0.00
Molecular Templates (MTEM) United States $0.555B 0.00
Ardelyx (ARDX) United States $0.550B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.519B 0.00
Innate Pharma SA (IPHYF) France $0.497B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.490B 11.85
Crinetics Pharmaceuticals (CRNX) United States $0.479B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.463B 18.06
Siga Technologies (SIGA) United States $0.455B 0.00
Flexion Therapeutics (FLXN) United States $0.454B 0.00
TherapeuticsMD (TXMD) United States $0.408B 0.00
DURECT (DRRX) United States $0.394B 0.00
Ocular Therapeutix (OCUL) United States $0.392B 0.00
Harpoon Therapeutics (HARP) United States $0.389B 0.00
Altimmune (ALT) United States $0.388B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.368B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.364B 0.00
Calithera Biosciences (CALA) United States $0.355B 0.00
Organogenesis Holdings (ORGO) United States $0.354B 0.00
MEI Pharma (MEIP) United States $0.348B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.292B 0.00
Concert Pharmaceuticals (CNCE) United States $0.292B 0.00
PROFOUND MEDICL (PROF) Canada $0.271B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.253B 0.00
Taiwan Liposome (TLC) Taiwan $0.237B 0.00
Redhill Biopharma (RDHL) Israel $0.224B 0.00
CASI Pharmaceuticals (CASI) United States $0.221B 0.00
Lannett Co Inc (LCI) United States $0.211B 4.64
KalVista Pharmaceuticals (KALV) United States $0.205B 0.00
Rafael Holdings (RFL) United States $0.197B 0.00
OptiNose (OPTN) United States $0.194B 0.00
Nature's Sunshine Products (NATR) United States $0.186B 24.46
IMV INC (IMV) Canada $0.185B 0.00
Jounce Therapeutics (JNCE) United States $0.173B 4.13
Nivalis Therapeutics (ALPN) United States $0.173B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.142B 0.00
Aquestive Therapeutics (AQST) United States $0.141B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.121B 0.00
Otonomy (OTIC) United States $0.120B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.113B 0.00
Champions Oncology (CSBR) United States $0.110B 0.00
Heat Biologics (HTBX) United States $0.108B 0.00
MediWound (MDWD) Israel $0.105B 0.00
Xeris Pharmaceuticals (XERS) United States $0.103B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.102B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.101B 0.00
Onconova Therapeutics (ONTX) United States $0.098B 0.00
Recro Pharma (REPH) United States $0.096B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.095B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.094B 0.00
CTI BioPharma (CTIC) United States $0.093B 0.00
Sundial Growers (SNDL) Canada $0.090B 0.00
Biomerica (BMRA) United States $0.086B 0.00
Aclaris Therapeutics (ACRS) United States $0.083B 0.00
Hemispherx BioPharma (AIM) United States $0.082B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.082B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.081B 0.00
ElectroCore (ECOR) United States $0.068B 0.00
SCYNEXIS (SCYX) United States $0.067B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.066B 0.00
Lipocine (LPCN) United States $0.060B 0.00
RENEURON GP (RNUGF) United Kingdom $0.059B 0.00
CV Sciences (CVSI) United States $0.057B 0.00
Addex Therapeutics (ADXN) Switzerland $0.057B 0.00
PolarityTE (PTE) United States $0.052B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.049B 29.09
Infinity Pharmaceuticals (INFI) United States $0.047B 0.00
Natural Alternatives (NAII) United States $0.046B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.045B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.045B 0.00
IsoRay (ISR) United States $0.044B 0.00
Forward Pharma (FWP) Denmark $0.041B 0.00
Mannatechorporated (MTEX) United States $0.041B 7.70
NovaBay Pharmaceuticals (NBY) United States $0.040B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.040B 86.09
Novan (NOVN) United States $0.040B 0.00
Jaguar Animal Health (JAGX) United States $0.039B 0.00
GTx (ONCT) United States $0.037B 0.00
AgeX Therapeutics (AGE) United States $0.035B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.034B 0.00
Neos Therapeutics (NEOS) United States $0.032B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.026B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.023B 0.00
India Globalization Capital (IGC) United States $0.022B 0.00
Iterum Therapeutics (ITRM) Ireland $0.020B 0.00
ProPhase Labs (PRPH) United States $0.019B 0.00
Bio-Path Holdings (BPTH) United States $0.018B 0.00
Flex Pharma (SLRX) United States $0.018B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.017B 0.00
Can-Fite Biopharma (CANF) Israel $0.016B 0.00
Regulus Therapeutics (RGLS) United States $0.016B 0.00
China SXT Pharmaceuticals (SXTC) China $0.014B 0.00
Shineco (TYHT) China $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 32.14
RXi Pharmaceuticals (PHIO) United States $0.013B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.013B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.009B 0.00
HANCOCK JAFFE (HJLI) United States $0.009B 0.00
Vical (BBI) United States $0.009B 0.00
Midatech Pharma (MTP) United Kingdom $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00